$59.84
0.71% yesterday
NYSE, May 20, 10:00 pm CET
ISIN
US2074101013
Symbol
CNMD

Conmed Corp. Stock price

$59.84
+12.18 25.56% 1M
-10.85 15.35% 6M
-8.60 12.57% YTD
-15.47 20.54% 1Y
-52.61 46.79% 3Y
-13.46 18.36% 5Y
+3.73 6.65% 10Y
NYSE, Closing price Tue, May 20 2025
-0.43 0.71%
ISIN
US2074101013
Symbol
CNMD
Sector

Key metrics

Market capitalization $1.85b
Enterprise Value $2.71b
P/E (TTM) P/E ratio 15.68
EV/FCF (TTM) EV/FCF 16.46
EV/Sales (TTM) EV/Sales 2.07
P/S ratio (TTM) P/S ratio 1.41
P/B ratio (TTM) P/B ratio 1.89
Dividend yield 1.34%
Last dividend (FY24) $0.80
Revenue growth (TTM) Revenue growth 4.20%
Revenue (TTM) Revenue $1.31b
EBIT (operating result TTM) EBIT $141.26m
Free Cash Flow (TTM) Free Cash Flow $164.55m
Cash position $35.49m
EPS (TTM) EPS $3.82
P/E forward 15.38
P/S forward 1.36
EV/Sales forward 1.99
Short interest 10.73%
Show more

Is Conmed Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Conmed Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Conmed Corp. forecast:

2x Buy
29%
5x Hold
71%

Analyst Opinions

7 Analysts have issued a Conmed Corp. forecast:

Buy
29%
Hold
71%

Financial data from Conmed Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,311 1,311
4% 4%
100%
- Direct Costs 617 617
1% 1%
47%
694 694
7% 7%
53%
- Selling and Administrative Expenses 442 442
12% 12%
34%
- Research and Development Expense 54 54
0% 0%
4%
198 198
1% 1%
15%
- Depreciation and Amortization 57 57
1% 1%
4%
EBIT (Operating Income) EBIT 141 141
1% 1%
11%
Net Profit 119 119
44% 44%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Conmed Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Conmed Corp. Stock News

Neutral
Seeking Alpha
20 days ago
CONMED Corporation (NYSE:CNMD ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Pat Beyer - Chief Executive Officer and President Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Matt O'Brien - Piper Sandler Robbie Marcus - JPMorgan Rick Wise - Stifel Young Li - Jefferies Travis Steed - Bank of America Mike Matson - ...
Neutral
Business Wire
20 days ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Sales of $321.3 million increased 2.9% year-over-year as reported and 3.8% in constant currency. Domestic revenue increased 4.2% year-over-year. International revenue increased 1.2% year-over-year as reported and 3.4% in consta...
Neutral
Business Wire
about 2 months ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2025 after the market close on Wednesday, April 30, 2025. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obt...
More Conmed Corp. News

Company Profile

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Head office United States
CEO Patrick Beyer
Employees 3,900
Founded 1970
Website www.conmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today